{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:53:17Z","timestamp":1762660397508},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,26]]},"DOI":"10.7759\/cureus.51112","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T14:10:13Z","timestamp":1703599813000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful Management of Persistent Gestational Trophoblastic Neoplasia: A Comprehensive Review and Case Analysis"],"prefix":"10.7759","author":[{"given":"Susmita","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusmita","family":"Sethy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth Sankar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan Kumar J","family":"Maniyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Current management of molar pregnancy","volume":"47","author":"Hancock BW","year":"2002","unstructured":"Hancock BW, Tidy JA. Current management of molar pregnancy. J Reprod Med. 2002, 47:347-54.","journal-title":"J Reprod Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612053352306","article-title":"Chorionic tumors","volume":"335","author":"Berkowitz RS","year":"1996","unstructured":"Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996, 335:1740-8. 10.1056\/NEJM199612053352306","journal-title":"N Engl J Med"},{"key":"ref3","article-title":"Complete hydatidiform mole. A disease with a changing profile","volume":"44","author":"Coukos G","year":"1999","unstructured":"Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I. Complete hydatidiform mole. A disease with a changing profile. J Reprod Med. 1999, 44:698-704.","journal-title":"J Reprod Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143 Suppl 2","author":"Ngan HY","year":"2018","unstructured":"Ngan HY, Seckl MJ, Berkowitz RS, et al.. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018, 143 Suppl 2:79-85. 10.1002\/ijgo.12615","journal-title":"Int J Gynaecol Obstet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.05.002","article-title":"Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?","volume":"138","author":"Sun SY","year":"2015","unstructured":"Sun SY, Melamed A, Goldstein DP, et al.. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?. Gynecol Oncol. 2015, 138:46-9. 10.1016\/j.ygyno.2015.05.002","journal-title":"Gynecol Oncol"},{"key":"ref6","article-title":"Hydatidiform mole: treatment and follow-up","author":"Berkowitz RS","year":"2023","unstructured":"Berkowitz RS, Horowitz NS, Elias KM. Hydatidiform mole: treatment and follow-up. UptoDate. Post TW, Chakrabarti A, Vora SR (ed): UptoDate, Waltham, MA; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational trophoblastic disease: current evaluation and management","volume":"137","author":"Soper JT","year":"2021","unstructured":"Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol. 2021, 137:355-70. 10.1097\/AOG.0000000000004240","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6934(03)00072-5","article-title":"Clinical presentation and management of molar pregnancy","volume":"17","author":"Sasaki S","year":"2003","unstructured":"Sasaki S. Clinical presentation and management of molar pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003, 17:885-92. 10.1016\/s1521-6934(03)00072-5","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01997","article-title":"Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios","volume":"153","author":"van Trommel NE","year":"2005","unstructured":"van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios. Eur J Endocrinol. 2005, 153:565-75. 10.1530\/eje.1.01997","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.12.008","article-title":"What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients","volume":"148","author":"Coyle C","year":"2018","unstructured":"Coyle C, Short D, Jackson L, et al.. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. Gynecol Oncol. 2018, 148:254-7. 10.1016\/j.ygyno.2017.12.008","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90295-0","article-title":"Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study)","volume":"160","author":"Curry SL","year":"1989","unstructured":"Curry SL, Schlaerth JB, Kohorn EI, et al.. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). Am J Obstet Gynecol. 1989, 160:805-11. 10.1016\/0002-9378(89)90295-0","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.031","article-title":"Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review","volume":"100","author":"Costa HL","year":"2006","unstructured":"Costa HL, Doyle P. Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review. Gynecol Oncol. 2006, 100:579-85. 10.1016\/j.ygyno.2005.09.031","journal-title":"Gynecol Oncol"},{"key":"ref13","article-title":"Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center","volume":"59","author":"Vargas R","year":"2014","unstructured":"Vargas R, Barroilhet LM, Esselen K, Diver E, Bernstein M, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014, 59:188-94.","journal-title":"J Reprod Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.3.594","article-title":"Repetitive complete hydatidiform mole can be biparental in origin and either male or female","volume":"15","author":"Fisher RA","year":"2000","unstructured":"Fisher RA, Khatoon R, Paradinas FJ, Roberts AP, Newlands ES. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod. 2000, 15:594-8. 10.1093\/humrep\/15.3.594","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007102.pub3","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"7","author":"Alazzam M","year":"2012","unstructured":"Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA. First-line chemotherapy in low-risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012, 7:CD007102. 10.1002\/14651858.CD007102.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007289.pub3","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","volume":"9","author":"Wang Q","year":"2017","unstructured":"Wang Q, Fu J, Hu L, et al.. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017, 9:CD007289. 10.1002\/14651858.CD007289.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.4386","article-title":"Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"29","author":"Osborne RJ","year":"2011","unstructured":"Osborne RJ, Filiaci V, Schink JC, et al.. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. J Clin Oncol. 2011, 29:825-31. 10.1200\/JCO.2010.30.4386","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.10.028","article-title":"Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: the New England Trophoblastic Disease Center experience","volume":"148","author":"Maest\u00e1 I","year":"2018","unstructured":"Maest\u00e1 I, Nitecki R, Horowitz NS, Goldstein DP, de Freitas Segalla Moreira M, Elias KM, Berkowitz RS. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: the New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018, 148:161-7. 10.1016\/j.ygyno.2017.10.028","journal-title":"Gynecol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.03.003","article-title":"Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia","volume":"125","author":"Lybol C","year":"2012","unstructured":"Lybol C, Sweep FC, Harvey R, et al.. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2012, 125:576-9. 10.1016\/j.ygyno.2012.03.003","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/214823-successful-management-of-persistent-gestational-trophoblastic-neoplasia-a-comprehensive-review-and-case-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:40Z","timestamp":1707509500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/214823-successful-management-of-persistent-gestational-trophoblastic-neoplasia-a-comprehensive-review-and-case-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.51112","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}